Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
coronavirus: Archive
Bull of the Day: DoorDash (DASH)
by Andrew Rocco
DoorDash stands out as a leader in the food delivery service industry. The company's strategic expansion beyond traditional partnerships will spur revenue growth. Furthermore, the "new economy" will benefit the company for years to come.
BIGNo Net Change DKSPositive Net Change SFMPositive Net Change GONegative Net Change DASHPositive Net Change
coronavirus earnings mobile software
Is it Time to Buy Pfizer, Moderna, or AstraZeneca's Stock?
by Shaun Pruitt
Despite slowing COVID-19 vaccine sales these healthcare titans are trading at more reasonable valuations with a lot of the risk-to-reward being priced into their stocks considering their earnings potential.
AZNPositive Net Change PFEPositive Net Change MRNAPositive Net Change
biotechnology cancer cell-therapy coronavirus earnings gene-therapy immuno-therapy investing medical messenger-rna pharmaceuticals vaccines
Stocks on the Mend: A Mean Reversion Duo
by Andrew Rocco
September is starting in classic, historically weak form. However, if the market finds it's footing, two stocks have explosive, reversion to the mean potential.
AMDPositive Net Change JNJNegative Net Change PFEPositive Net Change MRNAPositive Net Change NVAXPositive Net Change QQQPositive Net Change
biotechnology biotechs coronavirus investing semiconductor vaccines
Squeezing the Market: Riding the Rollercoaster of Short Squeeze Mania
by Andrew Rocco
Several stocks squeezed shorts Thursday. What does it mean for the market?
GMEPositive Net Change QQQPositive Net Change AMCPositive Net Change ARKKPositive Net Change CVNAPositive Net Change BYNDPositive Net Change SPCEPositive Net Change PLTRPositive Net Change
coronavirus e-commerce etfs investing reddit-stocks spac space
Bear of the Day: BioNTech (BNTX)
by Andrew Rocco
BNTX is ranked a lowly 5 for a reason. Earnings have peaked, COVID hysteria has subsided, and the technical picture is lagging.
PFEPositive Net Change BNTXPositive Net Change
biotechnology biotechs coronavirus
How Did COVID Reshape the Labor Markets
by John Blank
The latest research focuses on retirees.
NVOPositive Net Change SAPPositive Net Change STLAPositive Net Change
coronavirus economy
Boeing's Strength is Set to Continue Despite Q4 Loss
by Andrew Rocco
The world's largest aerospace company reported a Q4 loss of more than $600 million. Andrew Rocco breaks down why investors should look to the future and discount the past.
BAPositive Net Change LMTNegative Net Change DALPositive Net Change UALNegative Net Change RKLBPositive Net Change
aerospace airlines coronavirus earnings transportation travel-leisure
3 Under-$10 Drug Stocks Wall Street Analysts Recommend Buying
by Sundeep Ganoria
We present three small biotech stocks, which most analysts on Wall Street are optimistic about. These companies have upside potential for 2023 despite an uncertain macro environment.
ADAPPositive Net Change KMDANegative Net Change ZYMEPositive Net Change
biotechnology biotechs cancer cell-therapy coronavirus immuno-therapy inflation medical
S&P 500 Overtakes Key 4,000 Level: Stocks to Watch
by Bryan Hayes
Buying pressure accelerated Tuesday afternoon, as all sectors found positive territory.
NFLXNegative Net Change MPCNegative Net Change ARRYPositive Net Change
alt-energy consumer-discretionary coronavirus dividend-investing dividends earnings energy fang inflation interest-rate investing media oil-energy solar tech-stocks
Pfizer Earnings Preview: Growth & Diversification is Key
by Shaun Pruitt
Pfizer's (PFE) Q3 earnings report on Tuesday, November 1 will give insight into its ability to sustain growth from its Covid-19 vaccines. The company's ability to beat earnings expectations may rely on the growth of other business units during the quarter.
PFEPositive Net Change JNJNegative Net Change ABBVNegative Net Change
cancer coronavirus dividend-investing dividends earnings hospitals medical oncology-screening pharmaceuticals vaccines
The Meme Stock Resurgence: Is Now the Time to Buy?
by Bryan Hayes
Recent individual rallies suggest the meme stock movement is alive and well.
GMEPositive Net Change AMCPositive Net Change
coronavirus e-commerce earnings electronics gaming internet internet-content investing meme-stocks reddit-stocks social-media video-games
The Wind's at Your Back with This Shipping Sweetheart
by Bryan Hayes
Due to surges in global trade, shipping companies have witnessed a substantial improvement in terms of volumes and revenues.
coronavirus e-commerce earnings electronics investing transportation
Survive the Financial Armageddon Using the Zacks Rank
by Bryan Hayes
Investors can use this system to find companies that are primed to surge in price - even when most stocks are falling.
SQMPositive Net Change
agriculture basic-materials coronavirus earnings investing
Healthcare Outperformance May Signal Short-Term Market Bottom
by Bryan Hayes
This sector outperformance may be a sign the market is nearing a point of selling exhaustion.
JNJNegative Net Change XLVPositive Net Change
biotechnology biotechs cancer coronavirus dividend-investing dividends earnings etfs investing large-cap pharmaceuticals
The Commodity Surge: Is It Too Late to Buy These Leading Oil and Gas Stocks?
by Bryan Hayes
With crude prices continuing to move higher, investors would be wise to consider an allocation to these stocks.
COPPositive Net Change MROPositive Net Change
coronavirus earnings energy investing large-cap oil-energy
BioPharma Giants Print Fresh All-Time Highs
by Bryan Hayes
The trend is our friend in this market, and these two biopharmaceutical stocks are trending exceptionally well.
REGNNegative Net Change BMYPositive Net Change
biotechnology cancer cell-therapy coronavirus earnings genetics hospitals immuno-therapy investing large-cap medical medical-devices pharmaceuticals
Is It Time to Give Chinese Stocks the Green Light?
by Bryan Hayes
The notion of China weighing down emerging markets is far from a new reality.
JDPositive Net Change KWEBPositive Net Change
coronavirus e-commerce earnings emerging-markets etfs internet internet-content investing large-cap
Bull Of The Day: DocGo (DCGO)
by Brian Bolan
It may still be very early, but this company could change the way we think of non-emergency healthcare
DCGOPositive Net Change
autonomous-vehicles coronavirus medical-devices smart-health
Bull of the Day: Meridian Bioscience (VIVO)
by Kevin Cook
Beat-and-raise quarter launches shares and estimates as growth in diagnostics returns
coronavirus medical
Medical IT Providers Marching to Their Own Beat
by Bryan Hayes
Medical IT Providers Marching to Their Own Beat
MDRXPositive Net Change
artificial-intelligence cloud-computing coronavirus dividend-investing dividends earnings hospitals investing large-cap medical smart-health software vaccines
The Disinformation Effect: Media Companies Soar on Growth Prospects
by Bryan Hayes
The Disinformation Effect: Media Companies Soar on Growth Prospects
SSPPositive Net Change NXSTNegative Net Change
advertising coronavirus earnings internet internet-content investing media social-media
Stay to Play: Hotel Giants Displaying Relative Strength
by Bryan Hayes
Stay to Play: Hotel Giants Displaying Relative Strength
MARNegative Net Change IHGPositive Net Change
consumer-discretionary coronavirus dividend-investing dividends earnings investing large-cap restaurants travel-leisure
The Stealth Bear Market: Nearing an End or More Pain Ahead?
by Bryan Hayes
The Stealth Bear Market: Nearing an End or More Pain Ahead?
IMONegative Net Change CVEPositive Net Change
coronavirus dividend-investing dividends earnings energy investing large-cap oil-energy
The Stock-Picking Puzzle: Putting The Pieces Together
by Bryan Hayes
The Stock-Picking Puzzle: Putting The Pieces Together
MCKPositive Net Change HSICPositive Net Change
coronavirus dental dividend-investing dividends earnings hospitals investing large-cap medical medical-devices oncology-screening pharmaceuticals smart-health staffing vaccines
Bull of the Day: Pfizer Inc. (PFE)
by Bryan Hayes
With a dividend yield of 3% and a top Zacks VGM score of 'A', it's not hard to see why PFE is a top stock pick.
PFEPositive Net Change
biotechnology biotechs cancer cell-therapy coronavirus dividend-investing dividends earnings genetics hospitals immuno-therapy investing large-cap medical oncology-screening pharmaceuticals vaccines